REG - Uniphar PLC - AGM Statement

UnipharAnnouncement

Thu 07:01

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250508:nRSH7709Ha&default-theme=true

RNS Number : 7709H  Uniphar PLC  08 May 2025

 

 

AGM Statement

 

 

Dublin, London | 8 May 2025

 

Uniphar plc (the "Company" or "Uniphar") is holding its AGM today at 11am BST
at the office of William Fry, LLP, 6th Floor, 2 Grand Canal Square, Dublin 2,
D02 A342, Ireland.

 

At the AGM, Maurice Pratt, Chairman of Uniphar, will make the following
statement:

 

"I am pleased to report that 2024 was another successful year for Uniphar. The
Group delivered very strong organic gross profit growth of 8.2%, driven by
growth across each of our three divisions. Adjusted EPS growth was 12%, free
cash flow conversion was strong at 105.5% and we maintained modest leverage at
1.5x.

 

Our multi-year strategic capital expenditure in infrastructure and technology
is progressing to plan and we now confidently expect at least 80% of our 2028
EBITDA target of €200m to be achieved through organic growth.

 

I am pleased to report a good start to 2025, with performance in the first
four months in line with the Board's expectations. Uniphar remains well
positioned to deliver organic gross profit growth across each division in line
with previous guidance and to deliver on expectations for the full year.

 

Sustainability continues to form a key part of Uniphar's culture and business
practices, and we continue to make progress across all five of our
sustainability pillars.

 

Finally, I would like to thank our shareholders for their support. I'd also
like to express my appreciation for the considerable effort and unwavering
commitment from our Uniphar colleagues, management, fellow Directors and all
our global teams for their loyalty, diligence, and dedication during 2024."

 

 

--- ENDS ---

 

 

Contact details

 Uniphar Group                                            Tel: +353 (0) 1 428 7777

 Allan Smylie, Head of Strategy and IR

 Davy (Joint Corporate Broker, Nominated Advisor and      Tel: +353 (0) 1 679 6363

 Euronext Growth Listing Sponsor)

 Daragh O'Reilly

 Niall Gilchrist

 Ivan Murphy

 RBC Capital Markets (Joint Corporate Broker)             Tel: +44 (0) 20 7653 4000

 Jamil Miah

 Rupert Walford

 Stifel Nicolaus Europe Limited (Joint Corporate Broker)  Tel: +44 (0) 20 7710 7600

 Matt Blawat

 Ben Maddison

 Francis North

 Q4 PR                                                    Tel: +353 (0) 1 475 1444

 Iarla Mongey, Public Relations Advisor to Uniphar Group

 

 

About Uniphar plc

Headquartered in Dublin, Ireland, the Uniphar Group is an international
diversified healthcare services business servicing the requirements of more
than 200 multinational pharmaceutical and medical technology manufacturers
across three divisions - Uniphar Medtech, Uniphar Pharma and Uniphar Supply
Chain & Retail. The Group is active in Europe, North America, APAC and
MENA and delivers to 160+ countries.

 

Uniphar solves problems for healthcare. We sit in the middle between the
manufacturers and their stakeholders, and we help them both to overcome the
problems of a new, complicated healthcare environment. The Company's vision is
to improve patient access to pharmaco-medical products and treatments by
enhancing connectivity between manufacturers and healthcare professionals and
their patients. Uniphar represents a strong combination of scale, growth, and
profitability.

 

Uniphar Medtech

Uniphar Medtech is a leading pan-European medical device distributor and
solutions partner. The Group's strategy for Uniphar Medtech is to grow our
service offering across Europe and expand our addressable market by serving
new specialities and new manufacturers.

 

Uniphar Pharma

Uniphar Pharma operates a global business with high value services across the
lifecycle of a pharmaceutical product. We enable pharma and biotech companies
to bring innovative medicines to global markets and provide healthcare
professionals with access to medicines they cannot source through traditional
channels. Our strategy is to build a leading platform to provide the
specialist support and expertise needed to improve access to these medicines.

 

Uniphar Supply Chain & Retail

Uniphar Supply Chain & Retail is the leading pharmaceutical wholesaler in
Ireland with a growing symbol group offering of retail pharmacies. The Group's
strategy for Uniphar Supply Chain & Retail is to grow our wholesale market
share, our symbol group network and our own brand, in-licenced and consumer
products portfolio.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMFLFSREIIDIIE